Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-11-29 · accession 0001437749-24-036546 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-03 | 2024-11-29 | FLNA | Schoen Eric | CFO | M - OptEx | $1.18 | +50.0K | 71.3K | +235% | +$59.0K |
| DI | 2024-12-03 | 2024-11-29 | FLNA | Schoen Eric | CFO | S - Sale+OE | $3.82 | -2,000 | 0 | -100% | -$7,640 |
| D | 2024-12-03 | 2024-11-29 | FLNA | Schoen Eric | CFO | S - Sale+OE | $3.86 | -59.8K | 11.5K | -84% | -$230.8K |
| D | 2024-12-03 | 2024-11-29 | FLNA | Schoen Eric | CFO | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-29 | M | A | 50,000 | $1.18 | 71,300 | D By limited liability corporation | — | — | |
| 2 | Common | Common Stock | 2024-11-29 | S | D | 2,000 | $3.82 | 0 | I | — | — | |
| 3 | Common | Common Stock | 2024-11-29 | S | D | 59,800 | $3.86 | 11,500 | D | — | — | (F1) 1. The sale reported in column 4 is a weighted average price. The shares were sold in multiple open market transactions at prices ranging from $3.81 to $3.89 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-11-29 | M | D | 50,000 | $0.00 | 0 | D | $1.18 · 2018-11-30 to 2028-10-31 | 50,000 Common Stock |